Recent Updates
Recently added Catalysts
SGMT

Sagimet Biosciences Announces Poster Presentation at the 10th Annual MASH-TAG 2026 Conference

Thursday, January 8, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Sagimet Biosciences Announces Poster Presentation at the 10th Annual MASH-TAG 2026 Conference
Price reaction · baseline $5.52 (2026-01-07 close) · hit after-hours · clean, no other SGMT news in the window
day 0 close · peak
+0.9%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+110%
120-day peak, hindsight
Typical move
5.7%
average across 12 past catalysts
Cash runway
~69 mo
Minimal dilution risk
Lead asset
TVB-2640
Phase 2 · Metabolic Dysfunction-assocated Steatohepatitis/ Nonalcoholic Fatty Liver Disease

Full Press Release Details

Sagimet Biosciences Announces Poster Presentation at the 10th Annual MASH-TAG 2026 Conference.
ShareAdd on Google
Tags: SGMT Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Jan 8, 2026

Biotech snapshot

Cash runway
$258M liquidity · $4M/mo burn
~69 mo
Minimal dilution risk
Lead asset
TVB-2640Phase 2
Metabolic Dysfunction-assocated Steatohepatitis/ Nonalcoholic Fatty Liver Disease →

Catalyst track record

+110%
best trade around SGMT's most recent catalyst

Peak hindsight return over a 120-day window, across 12 tracked FDA/PDUFA catalysts for SGMT.

See every catalyst's timing & PoA →